Biggest News Aggregation in the World
📰 Presents News

Page 165 - Presents News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Presents. Real-time updates on events, politics, business and more.

Global Blood Therapeutics, Inc.: GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta (voxelotor) in Sickle Cell Disease

Positive results from Phase 1 study of GBT601, including incremental new data, support advancing into planned Phase 2/3 trial by mid-year GBT to hold investor conference call and webcast today at 3:00
United States United Arab Emirates United Kingdom Kim Smith Whitley Steven Immergut Informationfor Oxbryta

Samsung Bioepis Presents New Phase 3 Study of SB12 (Eculizumab), A Proposed Biosimilar to Soliris, at the European Hematology Association (EHA) Congress 2022

Phase 3 study demonstrated clinical equivalence in efficacy, safety, pharmacokinetics (PK), pharmacodynamics (PD), and immunogenicity of SB12 compared to reference eculizumab in paroxysmal nocturnal hemoglobinuria
Yoon Kim Kostenloser Wertpapierhandel Jane Chung Samsung Bioepis European Medicines Agency European Hematology Association

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Research and Markets: Insights on the Single Cell Sequencing Global Market to 2027 - Ongoing Demand for Personalized or Customized Medicine Presents Opportunities

The "Single Cell Sequencing Market Research Report by Product (Consumables and Instruments), Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East Africa) Global Forecast to
Kostenloser Wertpapierhandel Merck Millipore Laura Wood Agilent Technologies Inc Nanostring Technologies Inc Perkinelmer Inc

Wugen, Inc.: Wugen Presents New Preclinical Data Demonstrating Enhanced Anti-Tumor Activity of WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress

-- WU-NK-101 exhibited enhanced metabolic flexibility and resistance to tumor microenvironment (TME) immunosuppression relative to conventional natural killer (NK) cells -- -- WU-NK-101 demonstrated
Kostenloser Wertpapierhandel Dan Kemp Jan Davidson Moncada Elsie Yau Stern Investor Relations Inc Wugen Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science